Technical analysis of AEON Biopharma, Inc. (AEON): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc.
Price Performance
| 1 month | +4.90% |
| 3 months | -61.53% |
| Year-to-date | -76.64% |
| 1 year | -65.64% |
| 3 years | -99.94% |
52-Week Range
| 52-week High | $1.45 |
| 52-week Low | $0.18 |
| Avg Volume (90d) | 4.6M |
Technical Indicators
| SMA 50 | $0.29 |
| SMA 200 | $0.79 |
| Beta | 0.73 |
| 30-day Volatility (annualised) | 137.4% |
| Price vs SMA 50 | -10.3% |
| Price vs SMA 200 | -67.5% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $0.85 | |
| 2025-11 | $0.85 | -0.4% |
| 2025-12 | $1.10 | +29.9% |
| 2026-01 | $1.16 | +5.5% |
| 2026-02 | $1.12 | -3.4% |
| 2026-03 | $0.98 | -12.1% |
| 2026-04 | $0.92 | -6.3% |
| 2026-05 | $0.76 | -18.0% |
| 2026-06 | $0.72 | -4.9% |
| 2026-07 | $0.29 | -59.3% |
| 2026-08 | $0.30 | +1.0% |
| 2026-09 | $0.26 | -13.1% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.26 |
| Market Cap | $11M |
| Exchange | AMEX |
| Country | US |
Valuation Ratios
| Price / Book | -0.85 |
| EV / EBITDA | -0.54 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -0.18 |
| Current Ratio | 0.54 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -126.80 |